1. Home
  2. PACK vs ZVRA Comparison

PACK vs ZVRA Comparison

Compare PACK & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACK
  • ZVRA
  • Stock Information
  • Founded
  • PACK 1972
  • ZVRA 2006
  • Country
  • PACK United States
  • ZVRA United States
  • Employees
  • PACK N/A
  • ZVRA N/A
  • Industry
  • PACK Containers/Packaging
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PACK Consumer Discretionary
  • ZVRA Health Care
  • Exchange
  • PACK Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • PACK 447.2M
  • ZVRA 467.6M
  • IPO Year
  • PACK N/A
  • ZVRA 2015
  • Fundamental
  • Price
  • PACK $4.98
  • ZVRA $8.81
  • Analyst Decision
  • PACK Buy
  • ZVRA Strong Buy
  • Analyst Count
  • PACK 3
  • ZVRA 7
  • Target Price
  • PACK $7.17
  • ZVRA $21.71
  • AVG Volume (30 Days)
  • PACK 546.7K
  • ZVRA 1.6M
  • Earning Date
  • PACK 10-30-2025
  • ZVRA 11-05-2025
  • Dividend Yield
  • PACK N/A
  • ZVRA N/A
  • EPS Growth
  • PACK N/A
  • ZVRA N/A
  • EPS
  • PACK N/A
  • ZVRA 0.54
  • Revenue
  • PACK $388,100,000.00
  • ZVRA $84,388,000.00
  • Revenue This Year
  • PACK $10.95
  • ZVRA $336.43
  • Revenue Next Year
  • PACK $9.55
  • ZVRA $54.26
  • P/E Ratio
  • PACK N/A
  • ZVRA $16.43
  • Revenue Growth
  • PACK 9.54
  • ZVRA 244.60
  • 52 Week Low
  • PACK $2.91
  • ZVRA $6.19
  • 52 Week High
  • PACK $8.70
  • ZVRA $13.16
  • Technical
  • Relative Strength Index (RSI)
  • PACK 45.38
  • ZVRA 35.32
  • Support Level
  • PACK $4.99
  • ZVRA $9.67
  • Resistance Level
  • PACK $5.40
  • ZVRA $10.56
  • Average True Range (ATR)
  • PACK 0.36
  • ZVRA 0.55
  • MACD
  • PACK -0.05
  • ZVRA -0.25
  • Stochastic Oscillator
  • PACK 29.13
  • ZVRA 6.51

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: